We use neuroendocrine strategies to study the neurobiology of major depression. Studies over three decades suggest that neuroendocrine dysregulation in depression is an index of the altered brain function during the illness. Limbic brain areas are viewed as producing """"""""overdrive"""""""" of the hypothalamo-pituitary-adrenal (HPA) axis in depression. However, definite confirmation of this theory is lacking. The reason is that clinical HPA studies to date have relied on the indirect measures of plasma ACTH and cortisol to infer the extent of the central overdrive. Our data show that the pituitary gland in fact performs an impressive function of masking the central hyperactivity of the HPA axis. In our experiments the focus is on pituitary function in depression. We remove cortisol feedback using metyrapone (MET). The central dysregulation is then unmasked. In Experiment 1 we study the circadian rhythm of cortisol and ACTH. Pilot data indicate that under MET the central overdrive on the HPA axis is much more severe than was believed. Experiment 1 also may resolve persistent questions about adrenal cortical sensitivity to ACTH in depression. A further payoff from Experiment 1 will be to obtain the first unmasked information on the circadian organization of HPA activity in normal man and in depression. Our analytic strategy includes deconvolution methods of characterizing pulsatile hormone release over time. In Experiment 2, we study pituitary responsiveness to hCRF, using deconvolution methods to describe the early hormonal response phase. We document fast feedback effects of cortisol on ACTH responses, an effect that confounds current testing methods. We also unmask the pituitary with MET so as to eliminate both fast and delayed steroid feedback effects on the observed responsiveness of pituitary corticotroph cells to hCRF in depression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
2R01MH039593-08A1
Application #
2244801
Study Section
Clinical Neuroscience and Biological Psychopathology Review Committee (CNBP)
Project Start
1987-01-01
Project End
1998-05-31
Budget Start
1995-06-01
Budget End
1996-05-31
Support Year
8
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Duke University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Cassidy, F; Ritchie, J C; Carroll, B J (1998) Plasma dexamethasone concentration and cortisol response during manic episodes. Biol Psychiatry 43:747-54
Krishnan, K R; Ritchie, J C; Manepalli, A N et al. (1991) Role of serotonin in hypothalamo pituitary adrenal axis escape from dexamethasone suppression. Prog Neuropsychopharmacol Biol Psychiatry 15:637-42
Kayganich, K; Watson, J T; Kilts, C et al. (1990) Determination of plasma dexamethasone by chemical oxidation and electron capture negative ionization mass spectrometry. Biomed Environ Mass Spectrom 19:341-7
Ritchie, J C; Belkin, B M; Krishnan, K R et al. (1990) Plasma dexamethasone concentrations and the dexamethasone suppression test. Biol Psychiatry 27:159-73
Rao, V P; Krishnan, K R; Goli, V et al. (1989) Neuroanatomical changes and hypothalamo-pituitary-adrenal axis abnormalities. Biol Psychiatry 26:729-32
Lee, M A; Flegel, P; Cameron, O G et al. (1988) Chronic caffeine consumption and the dexamethasone suppression test in depression. Psychiatry Res 24:61-5
Lee, M A; Flegel, P; Greden, J F et al. (1988) Anxiogenic effects of caffeine on panic and depressed patients. Am J Psychiatry 145:632-5
Cameron, O G; Thomas, B; Tiongco, D et al. (1987) Hypercortisolism in diabetes mellitus. Diabetes Care 10:662-4
Grunhaus, L; Zelnik, T; Albala, A A et al. (1987) Serial dexamethasone suppression tests in depressed patients treated only with electroconvulsive therapy. J Affect Disord 13:233-40
Kumar, A; Shipley, J E; Eiser, A S et al. (1987) Clinical correlates of sleep onset REM periods in depression. Biol Psychiatry 22:1477-81

Showing the most recent 10 out of 12 publications